Nuvation Bio Inc. - Common Stock (NUVB)

Q2 2024 13F Holders as of 6/30/2024

Type / Class
Equity / Common Stock
Shares outstanding
339M
Number of holders
145
Total 13F shares, excl. options
153M
Shares change
+17.7M
Total reported value, excl. options
$445M
Value change
+$51M
Put/Call ratio
0.67
Number of buys
84
Number of sells
-55
Price
$2.92

Significant Holders of Nuvation Bio Inc. - Common Stock (NUVB) as of Q2 2024

165 filings reported holding NUVB - Nuvation Bio Inc. - Common Stock as of Q2 2024.
Nuvation Bio Inc. - Common Stock (NUVB) has 145 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 153M shares of 339M outstanding shares and own 44.96% of the company stock.
Largest 10 shareholders include FMR LLC (28.8M shares), EcoR1 Capital, LLC (19.2M shares), BlackRock Inc. (16.2M shares), Omega Fund Management, LLC (13.3M shares), VANGUARD GROUP INC (10.1M shares), Decheng Capital LLC (6.95M shares), STATE STREET CORP (3.98M shares), GEODE CAPITAL MANAGEMENT, LLC (3.83M shares), ABRAMS CAPITAL MANAGEMENT, L.P. (3.81M shares), and TANG CAPITAL MANAGEMENT LLC (3.75M shares).
This table shows the top 145 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.